Menin-MLL inhibitor-22
Menin-MLL inhibitor-22 (compound C20) is an orally active inhibitor of the interaction between menin and mixed lineage leukemia (MLL) (IC50=7 nM) . Menin-MLL inhibitor-22 binds menin protein and inhibits cancer cell growth (MV4 cells, IC50=0.3 μM) . Menin is a putative tumor suppressor associated with multiple endocrine neoplasia type 1 (MEN-1 syndrome) [1].
Product Specifications
CAS Number
[2851841-61-5]
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/menin-mll-inhibitor-22.html
Purity
99.85
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=S(C1=CC=C(N2CC(CN3CCC(NC4=NC=NC5=CC=C(N=C54)OCCN(C)C)CC3)C2)C=C1)(C6CC6)=O
Molecular Formula
C29H39N7O3S
Molecular Weight
565.73
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
Cgref1 (Cell Growth Regulator with EF hand Domain Protein 1, Cell Growth Regulatory gene 11 Protein, Hydrophobestin, Cgref1, Cgr11) (MaxLight 650)
Cgref1 (Cell Growth Regulator with EF hand Domain Protein 1, Cell Growth Regulatory gene 11 Protein, Hydrophobestin, Cgref1, Cgr11) (MaxLight 650)
Elmsan1 (NM_001163502) Mouse Tagged ORF Clone Lentiviral Particle
